Zehna Therapeutics is a startup based in the United States.
Zehna Therapeutics is a company headquartered in the United States.
Zehna Therapeutics is an early-stage biotech company developing small molecule inhibitors targeting gut microbial enzymes to treat chronic cardiometabolic diseases, with a lead focus on chronic kidney disease.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.